射血分数降低心衰合并阻塞性或中枢性睡眠呼吸暂停患者的夜间心律失常
该横断面分析基于ADVENT-HF试验,比较HFrEF患者中OSA、CSA与无至轻度睡眠呼吸暂停的夜间心律失常患病率。结果显示OSA和CSA组ESVEA、房颤及>10 PVCs/h的患病率均高于对照组,且OSA严重程度与房性早搏负荷相关。
要点
- HFrEF合并OSA或CSA者夜间ESVEA、房颤及频发PVCs患病率高于无至轻度睡眠呼吸暂停者
- OSA严重程度与夜间房性早搏负荷独立相关,但与房颤或>10 PVCs/h无关
- CSA严重程度与房颤或>10 PVCs/h无显著关联
核心结论
- 在HFrEF患者中,OSA或CSA患者夜间ESVEA、房颤和>10 PVCs/h的患病率高于无至轻度睡眠呼吸暂停者。
- OSA严重程度与夜间房性异位搏动负荷相关,但OSA或CSA严重程度与房颤或>10 PVCs/h无显著关联。
研究设计与样本
- ADVENT-HF试验的辅助横断面分析,比较HFrEF患者中OSA(AHI≥15 events/h,n=430)、CSA(AHI≥15 events/h,n=150)与对照(AHI<15 events/h,n=76)的夜间心律失常患病率。
- 夜间心律失常通过多导睡眠图心电信号评估,包括ESVEA、房颤/房扑和>10 PVCs/h。
主要发现
- ESVEA患病率在对照、OSA和CSA组分别为0%、9%和12%。
- 房颤患病率在对照、OSA和CSA组分别为9%、17%和27%。
- >10 PVCs/h患病率在对照、OSA和CSA组分别为45%、59%和63%。
- 多变量回归中,每增加10 events/h的阻塞性AHI,房性早搏/h增加22.4%(95% CI, 5.2-42.3; P=.009)。
- 阻塞性或中枢性AHI均与房颤或>10 PVC/h无显著关联。
关键数值与推荐
- ESVEA定义:房性早搏≥30/h或室上性心动过速≥20跳。
- OSA和CSA分组标准:AHI≥15 events/h;对照组AHI<15 events/h。
- 频发室性早搏标准:>10 PVCs/h。
临床怎么用
- 对HFrEF合并OSA或CSA的患者,应关注夜间房性及室性心律失常的筛查。
- OSA严重程度较高者可能房性早搏负荷更重,但OSA或CSA严重程度不能预测房颤或频发室早。
局限性
- 横断面设计不能推断因果关系。
- 对照组样本量较小(n=76)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both obstructive and central sleep apnea (CSA) may contribute to nocturnal cardiac arrhythmias (NCAs). Data are scarce regarding the prevalence of clinically important nocturnal atrial and ventricular arrythmias in patients with heart failure with reduced ejection fraction (HFrEF) and OSA or CSA. RESEARCH QUESTION: In a cohort of patients with HFrEF, how does the prevalence of NCA compare among those with OSA, CSA, and those with no to mild sleep apnea? Is the severity of OSA or CSA associated with atrial and ventricular NCAs? STUDY DESIGN AND METHODS: This cross-sectional analysis is an ancillary study of the Effect of Adaptive Servo Ventilation on Survival and Hospital Admissions in Heart Failure (ADVENT-HF) trial. We compared the prevalence of NCAs (excessive supraventricular ectopic activity [ESVEA], defined as premature atrial complexes ≥ 30/h or supraventricular tachycardia ≥ 20 beats); atrial fibrillation/flutter [AF]; and > 10 premature ventricular complexes [PVCs/h]) on ECGs from polysomnograms of patients with HFrEF between those with OSA (apnea-hypopnea index [AHI ≥ 15 events/h]), those with CSA (AHI ≥ 15 events/h), and those with no to mild sleep apnea (AHI < 15 events/h [control]). RESULTS: The prevalence of ESVEA was higher in patients with OSA (n = 430) and CSA (n = 150) compared with control participants (n = 76): 0%, 9%, and 12%, respectively. The prevalence of AF in the control, OSA, and CSA groups was 9%, 17%, and 27%; the prevalence of > 10 PVCs/h was 45%, 59%, and 63%. In multivariable regression analyses, premature atrial complexes/h was associated with OSA severity (obstructive AHI: 22.4% increase per 10 events/h [95% CI, 5.2-42.3; P = .009), although neither obstructive nor central AHI was associated with AF or > 10 PVC/h. INTERPRETATION: In patients with HFrEF, the prevalences of nocturnal ESVEA, AF, and PVC > 10/h were higher in those with OSA or CSA than in those without OSA or CSA, and OSA severity was related to the burden of nocturnal atrial ectopy. Severity of OSA or CSA was not significantly related to AF or > 10 PVC/h. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT01128816; URL: www. CLINICALTRIALS: gov.
引用
- Horvath CM, Fisser C, Floras JS, et al. Nocturnal Cardiac Arrhythmias in Heart Failure With Obstructive and Central Sleep Apnea. Chest. 2024. PMID: 39168180. doi:10.1016/j.chest.2024.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。